What is ANRO (ANRO) stock price today?

ANRO (ANRO) is currently trading at $28.67, up 0.7% today.

What is ANRO P/E ratio?

ANRO's P/E ratio is -6.29. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ANRO return on equity (ROE)?

ANRO's return on equity (ROE) is -38.86%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is ANRO's market cap?

ANRO has a market capitalization of $1.01B.

NYSE · Biotechnology

ANRO (ANRO) Stock

$28.67 +0.70% NYSE: ANRO Healthcare

Valuation

Metric	Value
Price	$28.67
Market Cap	$1.01B
P/E Ratio	-6.29
P/B Ratio	3.11
P/S Ratio	0.00
EPS (TTM)	$0.00
52-Week High	$28.67
52-Week Low	$2.15
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-38.86%
ROA	-21.71%
ROCE	-43.71%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.02
Current Ratio	16.18

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-12.0M	$-29.0M	$-38.0M	$-69.0M	$-66.0M
Net Profit	$-9.0M	$-28.0M	$-36.0M	$-61.0M	$-63.0M
EPS	$-0.36	$-1.08	$-1.35	$-2.50	$-2.19
Op Margin	-5740.9%	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$29.0M	$51.0M	$87.0M	$178.0M	$185.0M
Total Liabilities	$41.0M	$89.0M	$158.0M	$26.0M	$34.0M
Cash	$26.0M	$48.0M	$83.0M	$168.0M	$176.0M
Borrowings	$38.0M	$82.0M	$10.0M	$17.0M	$4.0M

Latest News

Alto Neuroscience Prices $100 Million Stock Offering MT Newswires · Jul 13, 2026 Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock Business Wire · Jul 13, 2026 Is Alto Neuroscience, Inc. (ANRO) Stock Positioned for Growth With New Insights Into Anhedonia Treatment? Insider Monkey · Jul 2, 2026 Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia Business Wire · Jun 15, 2026 Alpha Wave Global Initiates COPT Defense Properties Position, According to Recent SEC Filing Motley Fool · May 27, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-9.0M	$-20.0M	$-33.0M	$-47.0M	$-52.0M
Investing Cash Flow	$-1.0M	$-1.0M	$-1.0M	$-4.0M	$0
Financing Cash Flow	$0	$0	$-2.0M	$-3.0M	$0
Net Cash Flow	$22.0M	$23.0M	$34.0M	$86.0M	$8.0M
Free Cash Flow	$-10.0M	$-21.0M	$-34.0M	$-49.0M	$-52.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	-6.65
FCF Yield	-8.31%
Quick Ratio	20.52
Interest Coverage	-33.00
Return 1Y	774.59%
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held4.11%

Institutions Held74.13%

Institutions Float Held77.32%

Institutional Holder	Shares	Report Date
Alpha Wave Global, LP	3,707,757	2026-03-31
Commodore Capital Lp	2,723,196	2026-03-31
Vestal Point Capital, LP	2,064,075	2026-03-31
Perceptive Advisors Llc	2,009,893	2026-03-31
Spruce Street Capital LP	1,325,210	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACIU	$2.31	+0.22%	-4.04	$234.59M	0.00%
ALDX	$1.60	+3.23%	-2.77	$96.51M	0.00%
AMRNAmarin Corporation plc	$14.58	+0.80%	-9.00	$301.45M	0.00%
CLLSCellectis S.A.	$2.81	-2.26%	-4.14	$282.17M	0.00%
CTNM	$14.16	+2.16%	-6.62	$529.39M	0.00%

About ANRO

ANRO is led by CEO Amit Etkin, employs 76 people, headquartered in US, publicly traded since 2024.

ANRO stock trades at $28.67 with a market capitalization of $1.01B. The stock is valued at a price-to-earnings (P/E) ratio of -6.29, price-to-book of 3.11, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.15 and $28.67, and currently trades at its 52-week high.

On profitability, ANRO generates a return on equity (ROE) of -38.86%, return on capital employed of -43.71%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks NYSE High ROE Stocks All stock screens

Run Stock Screener Investing Guides